MEDICAMEN BIOTECH   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
MEDICAMEN BIOTECH Last 5 Year EBIT Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EBIT Margin(%) | 8.37 | 10.46 | 14.51 | 17.36 | 15.89 | 
What is the latest EBIT Margin ratio of MEDICAMEN BIOTECH ?
| Year | EBIT Margin | 
|---|---|
| Mar2025 | 8.37 | 
| Mar2024 | 10.46 | 
| Mar2023 | 14.51 | 
| Mar2022 | 17.36 | 
| Mar2021 | 15.89 | 
How is EBIT Margin of MEDICAMEN BIOTECH Trending?
| Years | EBIT Margin | % Change | |
|---|---|---|---|
| Mar2025 | 8.37 | -19.98 | |
| Mar2024 | 10.46 | -27.91 | |
| Mar2023 | 14.51 | -16.42 | |
| Mar2022 | 17.36 | 9.25 | |
| Mar2021 | 15.89 | - | |
Other Financial Ratios of MEDICAMEN BIOTECH
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare EBIT Margin ratio of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹523.1 Cr | 7.1% | 25.2% | -22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| MEDICAMEN BIOTECH |    7.1%  | 
                            
                     
                     25.2%  | 
                     
                     -22.5%  | 
                    
| SENSEX |    -1.4%  |    
                      
                    
                     3.1%  | 
                     
                     3.8%  | 
                    
You may also like the below Video Courses